Virtus Investment Advisers’s DexCom DXCM Stock Holding History

Virtus Investment Advisers’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-27,552	Closed	-$1.83M	–	466
2025 Q4	$1.83M	Buy	+27,552	New	+$1.78M	0.5%	78

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Virtus Investment Advisers's DXCM Position: Q1 2026 in Review

Virtus Investment Advisers sold out of DexCom (DXCM) in Q1 2026, closing a stake of 27,552 shares — an estimated $1.83M sold.

Virtus Investment Advisers first reported a position in DXCM in Q4 2025 and held it in 1 quarter. The position peaked at $1.83M in Q4 2025. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Virtus Investment Advisers reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
Virtus Investment Advisers sold 27,552 DexCom shares in Q1 2026, an estimated $1.83M.
Virtus Investment Advisers first reported a position in DexCom in Q4 2025 and held it in 1 quarter.
Virtus Investment Advisers's DexCom position peaked at $1.83M in Q4 2025.
960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.